InspireMD Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,873.00
2,818.00
2,310.00
1,894.00
2,761.00
3,601
Cost of Goods Sold (COGS) incl. D&A
2,283.00
1,708.00
2,606.00
1,792.00
2,176.00
2,606
Gross Income
2,590.00
1,110.00
296.00
102.00
585.00
995
SG&A Expense
16,434.00
24,249.00
13,207.00
7,750.00
8,817.00
8,606
EBIT
14,762.00
23,139.00
-
7,648.00
8,232.00
7,611
Unusual Expense
375.00
512.00
982.00
-
-
438
Non Operating Income/Expense
543.00
18.00
-
-
-
67
Interest Expense
13,598.00
1,452.00
1,096.00
812.00
179.00
-
Pretax Income
29,250.00
25,083.00
15,581.00
8,460.00
8,411.00
7,240
Income Tax
8.00
12.00
4.00
1.00
27.00
-
Consolidated Net Income
29,258.00
25,095.00
15,585.00
8,461.00
8,438.00
7,240
Net Income
29,258.00
25,095.00
15,585.00
8,461.00
8,438.00
7,240
Net Income After Extraordinaries
29,258.00
25,095.00
15,585.00
8,461.00
8,438.00
7,240
Net Income Available to Common
29,258.00
25,095.00
15,585.00
8,461.00
8,438.00
7,696
EPS (Basic)
12,162.04
6,212.27
48,868.63
207.55
22.65
16.67
Basic Shares Outstanding
2.40
4.00
0.30
40.70
372.50
461.50
EPS (Diluted)
12,192.76
6,203.74
48,867.93
207.72
22.65
16.67
Diluted Shares Outstanding
2.40
4.00
0.30
40.70
372.50
461.50
EBITDA
14,554.00
22,876.00
13,262.00
7,457.00
8,054.00
7,459
Other Operating Expense
918.00
-
-
-
-
-
Non-Operating Interest Income
28.00
2.00
-
-
-
-

About InspireMD

View Profile
Address
4 Menorat Hamaor Street
Tel Aviv TA 67448
Israel
Employees -
Website http://www.inspiremd.com
Updated 07/08/2019
InspireMD, Inc. is a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Tel Aviv, Israel.